Linatab M 2.5/500 TabDescriptionLINATAB M is a combination of 2 oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control in patients with type-2 diabetes mellitus: Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor and Metformin, a member of the biguanide ..
Empatab M 5/500DescriptionEmpagliflozin is an inhibitor of Sodium-glucose co-transporter 2 (SGLT2). By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.IndicationsEmpagliflozin is..
Emjard M 5/500 mg TabletIndication:Emjard™ M is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetesDosage & Administration:Starting dose of Emjard™ M should be individualized based on the patient’s current regimen.Recommended individ..
Jardimet 5/500 mg Tablet1. What is Jardimet®?Jardimet® is a combination of Empagliflozin, a Sodium-glucose cotransporter-2 (SGLT2) inhibitor and Metformin Hydrochloride, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus..
Liglimet 2.5/500 mg Tablet, 1 stripIndication:LiglimetTM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Linagliptin and Metformin is appropriate.Dosage & Administration:Dose of this combination should ..